REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 6th, 2022 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of July 5, 2022, between Adamis Pharmaceuticals Corporation, a Delaware corporation (the “Company”), and purchaser signatory hereto (the “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 6th, 2022 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of July 5, 2022, between Adamis Pharmaceuticals Corporation, a Delaware corporation (the “Company”), the purchaser identified on the signature pages hereto (including its successors and assigns, the “Purchaser”).
COMMON STOCK PURCHASE WARRANT ADAMIS PHARMACEUTICALS CORPORATIONAdamis Pharmaceuticals Corp • July 6th, 2022 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Lincoln Park Capital Fund, LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January 3, 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on January 5, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Adamis Pharmaceuticals Corporation, a Delaware corporation (the “Company”), up to 750,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of the Company’s Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
